Abstract OBJECTIVE: To investigate changes in the fraction of exhaled nitric oxide (FeNO) in childhood asthma, and to evaluate the clinical value of continuous monitoring of FeNO. METHODS: Twenty children with mild to moderate asthma were enrolled from the special outpatient clinic for asthma. Follow-up was performed at 8, 16, 24, 32 and 40 weeks after treatment. At each follow-up, asthmatic symptoms were recorded, pulmonary function was evaluated and FeNO was measured. RESULTS: The mean FeNO decreased rapidly 8 weeks after treatment and slowly afterwards. It decreased significantly 8,16,24 and 40 weeks after treatment (P<0.01). It increased significantly during acute attacks of asthma and decreased rapidly during periods of remission. There was significant negative correlation between FeNO and forced expiratory volume in one second (r =-0.193，P<0.05). The receiver operating characteristic curve of FeNO showed that FeNO had a sensitivity of 87.9% and a specificity of 80% for uncontrolled asthma when FeNO was 35.5 ppb, and that it had a sensitivity of 97% and a specificity of 27.1% when FeNO was 20.5 ppb. CONCLUSIONS: monitoring of FeNO can be used to evaluate the control level of airway inflammation in childhood asthma. When FeNO is less than 20.5 ppb, airway inflammation may be well controlled. When FeNO is more than 35.5 ppb, airway inflammation may be out of control. A sharp increase in FeNO suggests the possibility of acute asthma attack in children.
BAO Yan-Min,LIU Can-Xia,ZHENG Yue-Jie et al. Clinical value of continuous monitoring of fraction of exhaled nitric oxide in childhood asthma[J]. 中国当代儿科杂志, 2012, 14(11): 815-818.
BAO Yan-Min,LIU Can-Xia,ZHENG Yue-Jie et al. Clinical value of continuous monitoring of fraction of exhaled nitric oxide in childhood asthma[J]. CJCP, 2012, 14(11): 815-818.
［1］American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratorv nitric oxide and nasal nitric oxide［J］.Am J Respir Crit Care Med, 2005, 171(8): 912-930.
［4］Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ, et al. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans［J］. J Appl Physiol, 1999, 87(4): 1532-1542.
［5］Delclaux C, Zerah-Lancner F, Mahut B, Ribeil S, Dubois A, Larger C, et al. Alveolar nitric oxide and effect of deep inspiration during methacholine challenge［J］. Chest, 2005, 127(5): 1696-1702.
［6］Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review［J］. Chest, 2010(138): 682-692.
［8］Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma［J］. Thorax, 1999, 54(2): 108-114.
［9］Wong GW, Liu EK, Leung TF, Yung E, Ko FW, Hui DS, et al. High levels and gender difference of exhaled nitric oxide in Chinese school children ［J］. Clin Exp Allergy, 2005, 35(7): 889-893.
［10］Sonnappa S, Bastardo CW, Stafler P, Bush A, Aurora P, Stocks J. Ethnic differences in fraction of exhaled nitric oxide and lung function in healthy young children ［J］. Chest, 2011, 140(5): 1325-1331.
［11］Dweik RA, Boggs PB, Erzaram SC, Irvin CC, Leigh MW, Lundberg J, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications［J］. Am J Respir Crit Care Med, 2011, 184(5): 602-615.
